gestational diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. At 24-28 weeks of gestation, a 75g glucose tolerance test (OGTT) was performed, and the patients were diagnosed with gestational diabetes according to Guidelines for the Diagnosis and Treatment of Gestational Diabetes Mellitus (2014); 2. Single pregnancy; 3. Conventional medical nutrition treatment of blood glucose, without drug treatment of patients; 4. Voluntarily participate and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with serious systemic diseases requiring hospitalization; 2. Diabetic patients with pregnancy; 3. Patients with blood glucose treated with conventional medical nutrition and drug treatment; 4. Patients with incomplete data who have not received routine birth examination in our hospital; 5. Patients who have taken dietary fiber, probiotics or prebiotics within the last 1 month; 6. Patients who have a history of surgery to change the normal structure of the gastrointestinal tract, suffer from intestinal organic lesions, acute and chronic intestinal obstruction; 7. Patients with diseases deemed unsuitable for participation in this clinical trial by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycosylated serum protein (GSP); | — |
Secondary
| Measure | Time frame |
|---|---|
| Glycosylated hemoglobin A1c (HbA1c);Fasting insulin (FINS);Fasting blood glucose (FBG);2h postprandial blood glucose (2hPBG);Total cholesterol (TC);Triglyceride (TG);Low density lipoprotein cholesterol (LDL-C);High density lipoprotein cholesterol (HDL-C);Intestinal flora abundance ;Wexner assessment score;Bristol Score; | — |
Countries
China
Contacts
Qingdao Municipal Hospital